Stereotaxis, Inc. (STXS) stock
STXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/3018% below fair value
$0.95+0.06 (+7.26%)
Close on Nov 18, 2026Market cap $94.80MP/E –Yield –
Stereotaxis operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Stereotaxis's operating cash flow for the twelve months ending Jun 30, 2026 was -$15.29M. For fiscal 2025 it was -$13.69M. The highest annual figure on record is -$2.53M in fiscal 2015.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$13.69M | – |
| FY2024 | Dec 31, 2024 | -$8.50M | – |
| FY2023 | Dec 31, 2023 | -$9.14M | – |
| FY2022 | Dec 31, 2022 | -$8.42M | – |
| FY2021 | Dec 31, 2021 | -$2.95M | – |
| FY2020 | Dec 31, 2020 | -$3.51M | – |
| FY2019 | Dec 31, 2019 | -$4.62M | – |
| FY2018 | Dec 31, 2018 | -$2.55M | – |
| FY2017 | Dec 31, 2017 | -$4.67M | – |
| FY2016 | Dec 31, 2016 | -$6.56M | – |
| FY2015 | Dec 31, 2015 | -$2.53M | – |
| FY2014 | Dec 31, 2014 | -$9.09M | – |
| FY2013 | Dec 31, 2013 | -$6.33M | – |
| FY2012 | Dec 31, 2012 | -$12.12M | – |
| FY2011 | Dec 31, 2011 | -$31.57M | – |
| FY2010 | Dec 31, 2010 | -$18.91M | – |
| FY2009 | Dec 31, 2009 | -$22.31M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.68M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.44M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.97M | -413.5% |
| Q3 FY2025 | Sep 30, 2025 | -$4.20M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.73M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.78M | – |
| Q4 FY2024 | Dec 31, 2024 | $1.27M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.33M | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.09M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.35M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.44M | – |
| Q3 FY2023 | Sep 30, 2023 | -$967.00K | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.93M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.80M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.55M | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.53M | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.14M | -3444.1% |
| Q1 FY2022 | Mar 31, 2022 | -$2.19M | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.22M | -495.8% |
| Q3 FY2021 | Sep 30, 2021 | -$1.46M | – |
| Q2 FY2021 | Jun 30, 2021 | $34.00K | – |
| Q1 FY2021 | Mar 31, 2021 | -$305.00K | – |
| Q4 FY2020 | Dec 31, 2020 | $307.96K | – |
| Q3 FY2020 | Sep 30, 2020 | -$482.98K | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.17M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.17M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.91M | – |
| Q3 FY2019 | Sep 30, 2019 | -$405.85K | – |
| Q2 FY2019 | Jun 30, 2019 | -$518.94K | -205.9% |
| Q1 FY2019 | Mar 31, 2019 | -$1.78M | – |
| Q4 FY2018 | Dec 31, 2018 | -$777.08K | – |
| Q3 FY2018 | Sep 30, 2018 | -$238.35K | – |
| Q2 FY2018 | Jun 30, 2018 | $490.23K | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.02M | – |
| Q4 FY2017 | Dec 31, 2017 | -$802.75K | – |
| Q3 FY2017 | Sep 30, 2017 | -$491.31K | – |
| Q2 FY2017 | Jun 30, 2017 | -$713.20K | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.67M | – |
| Q4 FY2016 | Dec 31, 2016 | -$131.68K | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.82M | – |
See a number that looks wrong?